These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3235662)

  • 1. Human immune response to botulinum pentavalent (ABCDE) toxoid determined by a neutralization test and by an enzyme-linked immunosorbent assay.
    Siegel LS
    J Clin Microbiol; 1988 Nov; 26(11):2351-6. PubMed ID: 3235662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid.
    Pittman PR; Hack D; Mangiafico J; Gibbs P; McKee KT; Friedlander AM; Sjogren MH
    Vaccine; 2002 May; 20(16):2107-15. PubMed ID: 11972980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of neutralizing antibodies to type A, B, E, and F botulinum toxins in sera from human recipients of botulinum pentavalent (ABCDE) toxoid.
    Siegel LS
    J Clin Microbiol; 1989 Aug; 27(8):1906-8. PubMed ID: 2768475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccination of rabbits with an alkylated toxoid rapidly elicits potent neutralizing antibodies against botulinum neurotoxin serotype B.
    Held DM; Shurtleff AC; Fields S; Green C; Fong J; Jones RG; Sesardic D; Buelow R; Burke RL
    Clin Vaccine Immunol; 2010 Jun; 17(6):930-6. PubMed ID: 20410329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid.
    Torii Y; Tokumaru Y; Kawaguchi S; Izumi N; Maruyama S; Mukamoto M; Kozaki S; Takahashi M
    Vaccine; 2002 Jun; 20(19-20):2556-61. PubMed ID: 12057613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New equine antitoxins to botulinum neurotoxins serotypes A and B.
    Li D; Mattoo P; Keller JE
    Biologicals; 2012 Jul; 40(4):240-6. PubMed ID: 22560800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against botulinum toxins provided by passive immunization with botulinum human immune globulin: evaluation using an inhalation model.
    Gelzleichter TR; Myers MA; Menton RG; Niemuth NA; Matthews MC; Langford MJ
    J Appl Toxicol; 1999 Dec; 19 Suppl 1():S35-8. PubMed ID: 10594898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay.
    Shone C; Wilton-Smith P; Appleton N; Hambleton P; Modi N; Gatley S; Melling J
    Appl Environ Microbiol; 1985 Jul; 50(1):63-7. PubMed ID: 3927840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of new formalin-detoxified botulinum neurotoxin toxoids.
    Keller JE
    Clin Vaccine Immunol; 2008 Sep; 15(9):1374-9. PubMed ID: 18667637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notice of CDC's discontinuation of investigational pentavalent (ABCDE) botulinum toxoid vaccine for workers at risk for occupational exposure to botulinum toxins.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(42):1454-5. PubMed ID: 22031218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a botulinum fragment C-based ELISA for measuring the humoral immune response in primates.
    Lindsey CY; Smith LA; West MW; Boles JW; Brown JE
    Biologicals; 2003 Mar; 31(1):17-24. PubMed ID: 12623056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative vaccination against equine botulism (BoNT/C).
    Frey J; Eberle S; Stahl C; Mazuet C; Popoff M; Schatzmann E; Gerber V; Dungu B; Straub R
    Equine Vet J; 2007 Nov; 39(6):516-20. PubMed ID: 18065309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme-linked immunosorbent assay-enzyme-linked coagulation assay for detection of antibodies to Clostridium botulinum neurotoxins A, B, and E and solution-phase complexes.
    Doellgast GJ; Triscott MX; Beard GA; Bottoms JD
    J Clin Microbiol; 1994 Mar; 32(3):851-3. PubMed ID: 8195408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphtheria.
    Lagergård T; Trollfors B; Claesson BA; Karlberg J; Taranger J
    Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):341-5. PubMed ID: 1396754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response of horses to vaccination with the recombinant Hc domain of botulinum neurotoxin types C and D.
    Stahl C; Unger L; Mazuet C; Popoff M; Straub R; Frey J
    Vaccine; 2009 Sep; 27(41):5661-6. PubMed ID: 19646409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenicity in humans of a botulinum type F vaccine.
    Montgomery VA; Makuch RS; Brown JE; Hack DC
    Vaccine; 1999 Nov; 18(7-8):728-35. PubMed ID: 10547433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of horses with Crotalus durissus terrificus (South American rattlesnake) venom. A comparison of four different procedures.
    Freitas TV; Fortes-Dias CL; Diniz CR; Velarde DT; Freitas CF
    Braz J Med Biol Res; 1991; 24(3):281-90. PubMed ID: 1823242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Egg yolk antibodies for detection and neutralization of Clostridium botulinum type A neurotoxin.
    Trott DL; Yang M; Gonzalez J; Larson AE; Tepp WH; Johnson EA; Cook ME
    J Food Prot; 2009 May; 72(5):1005-11. PubMed ID: 19517727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross reaction of tetanus and botulinum neurotoxins A and B and the boosting effect of botulinum neurotoxins A and B on a primary anti-tetanus antibody response.
    Dolimbek BZ; Jankovic J; Atassi MZ
    Immunol Invest; 2002; 31(3-4):247-62. PubMed ID: 12472183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.